Literature DB >> 25820671

Interaction Between Brain Histamine and Serotonin, Norepinephrine, and Dopamine Systems: In Vivo Microdialysis and Electrophysiology Study.

Gunnar Flik1, Joost H A Folgering, Thomas I H F Cremers, Ben H C Westerink, Eliyahu Dremencov.   

Abstract

Brain monoamines (serotonin, norepinephrine, dopamine, and histamine) play an important role in emotions, cognition, and pathophysiology and treatment of mental disorders. The interactions between serotonin, norepinephrine, and dopamine were studied in numerous works; however, histamine system received less attention. The aim of this study was to investigate the interactions between histamine and other monoamines, using in vivo microdialysis and electrophysiology. It was found that the inverse agonist of histamine-3 receptors, thioperamide, increased the firing activity of dopamine neurons in the ventral tegmental area. Selective agonist of histamine-3 receptors, immepip, reversed thiperamide-induced stimulation of firing activity of dopamine neurons. The firing rates of serotonin and norpeinephrine neurons were not attenuated by immepip or thioperamide. Thioperamide robustly and significantly increased extracellular concentrations of serotonin, norepinephrine, and dopamine in the rat prefrontal cortex and slightly increased norepinephrine and dopamine levels in the tuberomammillary nucleus of the hypothalamus. It can be concluded that histamine stimulates serotonin, norepinephrine, and dopamine transmission in the brain. Modulation of firing of dopamine neurons is a key element in functional interactions between histamine and other monoamines. Antagonists of histamine-3 receptors, because of their potential ability to stimulate monoamine neurotransmission, might be beneficial in the treatment of mental disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25820671     DOI: 10.1007/s12031-015-0536-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  51 in total

1.  Histaminergic H(2) blockade facilitates ischemic release of dopamine in gerbil striatum.

Authors:  Naoto Adachi; Kin'ya Terao; Ryu Otsuka; Tatsuru Arai
Journal:  Brain Res       Date:  2002-02-01       Impact factor: 3.252

Review 2.  Therapeutic potential of histamine H3 receptor agonists and antagonists.

Authors:  R Leurs; P Blandina; C Tedford; H Timmerman
Journal:  Trends Pharmacol Sci       Date:  1998-05       Impact factor: 14.819

3.  Effect of R-(-)-alpha-methylhistamine and thioperamide on in vivo release of norepinephrine in the rat hippocampus.

Authors:  G Di Carlo; P Ghi; M Orsetti
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2000-02       Impact factor: 5.067

4.  Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.

Authors:  Gerard B Fox; Timothy A Esbenshade; Jia Bao Pan; Richard J Radek; Kathleen M Krueger; Betty B Yao; Kaitlin E Browman; Michael J Buckley; Michael E Ballard; Victoria A Komater; Holly Miner; Min Zhang; Ramin Faghih; Lynne E Rueter; R Scott Bitner; Karla U Drescher; Jill Wetter; Kennan Marsh; Martine Lemaire; Roger D Porsolt; Youssef L Bennani; James P Sullivan; Marlon D Cowart; Michael W Decker; Arthur A Hancock
Journal:  J Pharmacol Exp Ther       Date:  2004-12-17       Impact factor: 4.030

5.  Histamine H1 receptor antagonists produce increases in extracellular acetylcholine in rat frontal cortex and hippocampus.

Authors:  H C Dringenberg; M A De Souza-Silva; J Rossmüller; J P Huston; R K Schwarting
Journal:  J Neurochem       Date:  1998-04       Impact factor: 5.372

6.  Imidazole H3-antagonists: relationship between structure and ex vivo binding to rat brain H3-receptors.

Authors:  Federica Vacondio; Marco Mor; Claudia Silva; Valentina Zuliani; Mirko Rivara; Silvia Rivara; Fabrizio Bordi; Pier Vincenzo Plazzi; Francesca Magnanini; Simona Bertoni; Vigilio Ballabeni; Elisabetta Barocelli; Pierre-Alain Carrupt; Bernard Testa
Journal:  Eur J Pharm Sci       Date:  2004-09       Impact factor: 4.384

7.  Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat.

Authors:  Patrizia Giannoni; Maria-Beatrice Passani; Daniele Nosi; Paul L Chazot; Fiona C Shenton; Andrew D Medhurst; Leonardo Munari; Patrizio Blandina
Journal:  Eur J Neurosci       Date:  2009-05-22       Impact factor: 3.386

8.  Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release.

Authors:  Patrik Munzar; Gianluigi Tanda; Zuzana Justinova; Steven R Goldberg
Journal:  Neuropsychopharmacology       Date:  2004-04       Impact factor: 7.853

9.  Histaminergic system in the tree shrew brain.

Authors:  M S Airaksinen; G Flügge; E Fuchs; P Panula
Journal:  J Comp Neurol       Date:  1989-08-15       Impact factor: 3.215

Review 10.  The histaminergic network in the brain: basic organization and role in disease.

Authors:  Pertti Panula; Saara Nuutinen
Journal:  Nat Rev Neurosci       Date:  2013-07       Impact factor: 34.870

View more
  19 in total

1.  Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for restless legs syndrome.

Authors:  Félix Javier Jiménez-Jiménez; Elena García-Martín; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán-Pascual; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Sara Ortega-Cubero; Pau Pastor; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Esteban García-Albea; José A G Agúndez
Journal:  J Neural Transm (Vienna)       Date:  2016-11-11       Impact factor: 3.575

2.  Mechanism of Histamine Oxidation and Electropolymerization at Carbon Electrodes.

Authors:  Pumidech Puthongkham; Scott T Lee; B Jill Venton
Journal:  Anal Chem       Date:  2019-06-13       Impact factor: 6.986

Review 3.  The Role of the Central Histaminergic System in Behavioral State Control.

Authors:  Elda Arrigoni; Patrick M Fuller
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.

Authors:  Ranjana Patnaik; Aruna Sharma; Stephen D Skaper; Dafin F Muresanu; José Vicente Lafuente; Rudy J Castellani; Ala Nozari; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 5.  Monoaminergic neuropathology in Alzheimer's disease.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles R Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude M Wischik; Patrick R Hof
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

6.  4-Hydroxypiperidines and Their Flexible 3-(Amino)propyloxy Analogues as Non-Imidazole Histamine H₃ Receptor Antagonist: Further Structure⁻Activity Relationship Exploration and In Vitro and In Vivo Pharmacological Evaluation.

Authors:  Beata Olszewska; Anna Stasiak; Daniel McNaught Flores; Wiesława Agnieszka Fogel; Rob Leurs; Krzysztof Walczyński
Journal:  Int J Mol Sci       Date:  2018-04-19       Impact factor: 5.923

Review 7.  Monoaminergic Modulation of Motor Cortex Function.

Authors:  Clément Vitrac; Marianne Benoit-Marand
Journal:  Front Neural Circuits       Date:  2017-10-09       Impact factor: 3.492

8.  Neurotransmitter networks in mouse prefrontal cortex are reconfigured by isoflurane anesthesia.

Authors:  Xiaoying Zhang; Aaron G Baer; Joshua M Price; Piet C Jones; Benjamin J Garcia; Jonathon Romero; Ashley M Cliff; Weidong Mi; James B Brown; Daniel A Jacobson; Ralph Lydic; Helen A Baghdoyan
Journal:  J Neurophysiol       Date:  2020-04-29       Impact factor: 2.714

9.  Genetic lesioning of histamine neurons increases sleep-wake fragmentation and reveals their contribution to modafinil-induced wakefulness.

Authors:  Xiao Yu; Ying Ma; Edward C Harding; Raquel Yustos; Alexei L Vyssotski; Nicholas P Franks; William Wisden
Journal:  Sleep       Date:  2019-05-01       Impact factor: 5.849

Review 10.  Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis.

Authors:  Aurore Brunet; Geoffrey Stuart-Lopez; Thibaut Burg; Jelena Scekic-Zahirovic; Caroline Rouaux
Journal:  Front Neurosci       Date:  2020-04-29       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.